MediciNova
MNOV
16 hedge funds and large institutions have $4.33M invested in MediciNova in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
7% more funds holding
Funds holding: 15 → 16 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less capital invested
Capital invested by funds: $5.25M → $4.33M (-$912K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$11.8K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.35K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.53K |
| 4 |
Morgan Stanley
New York
|
+$236 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$146 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FNYS
First New York Securities
New York
|
-$73K |
| 2 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
-$17.7K |
MNOV Hedge Fund Activity: Q4 2013 in Review
16 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q4 2013, worth a combined $4.33M — down 17% from $5.25M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MNOV positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Macquarie Group, opening a new position worth an estimated $11.8K. The largest seller was First New York Securities, exiting entirely with an estimated $73K sold.
- 16 institutional investors held MediciNova (MNOV) as of Q4 2013, up from 15 in Q3 2013.
- Funds reported $4.33M of MediciNova stock for Q4 2013, down 17% quarter-over-quarter.
- 2 funds opened new MediciNova positions in Q4 2013 and 1 closed out, a net change of +1 holder.
- The largest MediciNova buyer in Q4 2013 was Macquarie Group, an estimated $11.8K added.
- The largest MediciNova seller in Q4 2013 was First New York Securities, an estimated $73K sold.
Based on aggregated 13F filings for Q4 2013.